2003
Relation between the degree of procedural anticoagulation and complications after coronary stent implantation
Ashby DT, Dangas G, Aymong EA, Farkouh ME, Mehran R, Lansky AJ, Moses JW, Leon MB, Stone GW. Relation between the degree of procedural anticoagulation and complications after coronary stent implantation. The American Journal Of Cardiology 2003, 92: 319-322. PMID: 12888144, DOI: 10.1016/s0002-9149(03)00637-4.Peer-Reviewed Original Research
2002
The HEP@NET study: an internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation
Mehran R, Lotan C, Kranjec I, Holmer E, Haase K, Camenzind E, Zelizko M, Maillard L, Seabra-Gomes R, Vandormael M, Lansky A, Dangas G, Stone G, Ashby D, Leon M. The HEP@NET study: an internet-based registry examining the efficacy of heparin coating in patients undergoing coronary stent implantation. Journal Of The American College Of Cardiology 2002, 39: 75. DOI: 10.1016/s0735-1097(02)80322-9.Peer-Reviewed Original Research
1998
Heparin dosing in patients undergoing coronary intervention
Popma J, Prpic R, Lansky A, Piana R. Heparin dosing in patients undergoing coronary intervention. The American Journal Of Cardiology 1998, 82: 19p-24p. PMID: 9809888, DOI: 10.1016/s0002-9149(98)00759-0.Peer-Reviewed Original ResearchConceptsIIb/IIIa inhibitorsCoronary interventionHeparin therapyHemochron devicePlatelet glycoprotein IIb/IIIa inhibitorsGlycoprotein IIb/IIIa inhibitorsGP IIb/IIIa inhibitorsUncomplicated coronary interventionsWeight-adjusted heparinAntithrombotic regimenHemoTec deviceHeparin bolusHeparin dosingSufficient heparinHeparin administrationConventional heparinUnfractionated heparinSignificant thrombocytopeniaPatientsACT levelsHeparinLonger durationTarget ACTInterventionAnticoagulation